Your browser doesn't support javascript.
loading
Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma.
Lazaridou, Maria-Filothei; Massa, Chiara; Handke, Diana; Mueller, Anja; Friedrich, Michael; Subbarayan, Karthikeyan; Tretbar, Sandy; Dummer, Reinhard; Koelblinger, Peter; Seliger, Barbara.
Affiliation
  • Lazaridou MF; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Magdeburger Str. 2, 06112 Halle, Germany.
  • Massa C; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Magdeburger Str. 2, 06112 Halle, Germany.
  • Handke D; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Magdeburger Str. 2, 06112 Halle, Germany.
  • Mueller A; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Magdeburger Str. 2, 06112 Halle, Germany.
  • Friedrich M; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Magdeburger Str. 2, 06112 Halle, Germany.
  • Subbarayan K; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Magdeburger Str. 2, 06112 Halle, Germany.
  • Tretbar S; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Magdeburger Str. 2, 06112 Halle, Germany.
  • Dummer R; Institute of Dermatology, University Hospital Zürich, 8091 Zürich, Switzerland.
  • Koelblinger P; Department of Dermatology and Allergology, University Hospital Salzburg, 5020 Salzburg, Austria.
  • Seliger B; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Magdeburger Str. 2, 06112 Halle, Germany.
J Clin Med ; 9(9)2020 Aug 20.
Article in En | MEDLINE | ID: mdl-32825219
ABSTRACT
The underlying molecular mechanisms of the aberrant expression of components of the HLA class I antigen processing and presentation machinery (APM) in tumors leading to evasion from T cell-mediated immune surveillance could be due to posttranscriptional regulation mediated by microRNAs (miRs). So far, some miRs controlling the expression of different APM components have been identified. Using in silico analysis and an miR enrichment protocol in combination with small RNA sequencing, miR-26b-5p and miR-21-3p were postulated to target the 3' untranslated region (UTR) of the peptide transporter TAP1, which was confirmed by high free binding energy and dual luciferase reporter assays. Overexpression of miR-26b-5p and miR-21-3p in melanoma cells downregulated the TAP1 protein and reduced expression of HLA class I cell surface antigens, which could be reverted by miR inhibitors. Moreover, miR-26b-5p overexpression induced a decreased T cell recognition. Furthermore, an inverse expression of miR-26b-5p and miR-21-3p with TAP1 was found in primary melanoma lesions, which was linked with the frequency of CD8+ T cell infiltration. Thus, miR-26-5p and miR-21-3p are involved in the HLA class I-mediated immune escape and might be used as biomarkers or therapeutic targets for HLA class Ilow melanoma cells.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Guideline / Risk_factors_studies Language: En Journal: J Clin Med Year: 2020 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Guideline / Risk_factors_studies Language: En Journal: J Clin Med Year: 2020 Document type: Article Affiliation country: